Company news

Immutep Ltd news in 2020

Immutep Ltd's news releases, calls and decks from 2020, newest first.

View company

Immutep granted US patent for eftilagimod alpha with a PD-1

December 29, 2020

Immutep Upscales Efti Manufacturing

December 16, 2020

Immuteps partner EOC pharma to start Ph II trial in MBC

December 9, 2020

Proposed issue of Securities - IMM

November 18, 2020

Pause in Trading

November 17, 2020

Encouraging Phase II TACTI-002 data reported at SITC 2020

November 9, 2020

Immutep Announces Australian Patent Grant for IMP701

November 8, 2020

Immutep enters into a Licence & Collaboration with LabCorp

October 29, 2020

2020 AGM Presentation

October 26, 2020

COVID-19 phase 2 investigator initiated trial commences

October 22, 2020

Immutep granted European patent for IMP761

October 21, 2020

Immutep reports improving results from INSIGHT-004 trial

September 17, 2020

IMM & Monash Uni receive funding grant for LAG-3 Research

August 30, 2020

Appendix 4E & 2020 Full Year Statutory Accounts

August 25, 2020

Recruitment of stage 1 of part B in TACTI-002 study complete

August 17, 2020

Immutep granted US patent for eftilagimod alpha

August 11, 2020

US patent granted for IMP701 antibody

July 14, 2020

Immutep Completes Recruitment for Part A of TACTI-002 trial

June 28, 2020

Immutep receives A$1,437,826 R&D Tax Incentive

June 21, 2020

Immutep announces improving data from TACTI-002 ph II trial

May 31, 2020

Immutep receives $3.6M R&D French tax incentive

May 28, 2020

Immutep granted Japanese patent for eftilagimod alpha

May 6, 2020

INSIGHT-004 and TACTI-002 data to be presented at ASCO

April 29, 2020

Immutep Investor Presentation

April 28, 2020

Immutep Reports Positive Phase II TACTI-002 Data

April 27, 2020

Enrollment completed for the INSIGHT-004 Study

April 21, 2020

Immutep March Quarterly Activities Report & Appendix 4C

April 20, 2020

Immutep advances its LAG-3 agonist for autoimmune diseases

April 15, 2020

Immutep presents TACTI-002 data at AACR Virtual Meeting

April 14, 2020

EOC Pharma confirms plans to advance Efti in China for MBC

April 8, 2020

Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides

March 25, 2020

Immutep reports supportive efficacy data from AIPAC study

March 24, 2020

Immutep receives 2nd IND approval for efti from US FDA

March 8, 2020

Immutep reports positive TACTI-002 data

February 18, 2020

Immutep Activities Report

January 28, 2020

Immutep expands Part C of TACTI-002 due to positive data

January 8, 2020

Decks in 2020